Close X
Thursday, November 21, 2024
ADVT 
Health

B.C. aims to expand access to menstrual products

Darpan News Desk The Canadian Press, 27 May, 2022 01:47 PM
  • B.C. aims to expand access to menstrual products

BURNABY, B.C. - The British Columbia government says it is providing $750,000 to expand access to free menstrual products for people who need them and to help the United Way establish a task force to consider how to end "period poverty."

Nicholas Simons, the minister of social development and poverty reduction, says half of the people who menstruate in B.C. have struggled to buy the products they need at some point in their lives.

He told a Friday news conference that no one should have to stay home from work or school or choose between hygiene and essentials like food.

Asked about earlier calls for the province to make menstrual products available at locations such as schools, workplaces, pharmacies and government offices, Simons says there's a big difference between having the products available at home and having to access them in public spaces.

He says previous research has shown that limited access to menstrual products means people are likely to stay at home, and the task force will look at where the most effective locations might be to make products available.

Neal Adolph with the United Way says half of the funding that's intended to last for two years will go to the task force and the other half will support the organization's work to increase access to menstrual products across B.C.

The period poverty task force is due to provide a final report in March 2024.

The task force will be chaired by Nikki Hill, who has previously worked on a provincially funded research project with the United Way looking at the impacts a lack of access to menstrual products can have on a person's life.

"Before we started some of this work, we had no idea what a common problem it was for people in our communities," Hill told the news conference.

The task force will look at creating equity for those people, she says.

Students have had access to free menstrual products in the washrooms of B.C. public schools since 2019, the Ministry of Social Development says.

MORE Health ARTICLES

ER visits down 25 per cent in early 2020: report

ER visits down 25 per cent in early 2020: report
A new report finds emergency department visits dropped by 25 per cent in the early days of the COVID-19 pandemic.

ER visits down 25 per cent in early 2020: report

UN cautions that virus plasma treatment still experimental

UN cautions that virus plasma treatment still experimental
The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment has many scientists afraid formal studies will be derailed.

UN cautions that virus plasma treatment still experimental

Pandemic pushes expansion of 'hospital-at-home' treatment

Pandemic pushes expansion of 'hospital-at-home' treatment
As hospitals care for people with COVID-19 and try to keep others from catching the virus, more patients are opting to be treated where they feel safest: at home.

Pandemic pushes expansion of 'hospital-at-home' treatment

Pharmacists can give childhood shots, U.S. officials say

Pharmacists can give childhood shots, U.S. officials say
Pharmacists in all 50 states are now allowed to give childhood vaccinations under a new directive aimed at preventing future outbreaks of measles and other preventable diseases.

Pharmacists can give childhood shots, U.S. officials say

Trail of bubbles leads scientists to new coronavirus clue

Trail of bubbles leads scientists to new coronavirus clue
A doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Trail of bubbles leads scientists to new coronavirus clue

FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy
Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment.

FDA blocks much-anticipated BioMarin hemophilia gene therapy